Projects

RNDr. Katarína Grossmannová, PhD.

National

Current
  • Orchestration of tumor and immune microenvironment in renal cell carcinoma and significance of tumor organoids in predicting therapy response
    Program: SRDA
    Duration: 1. 7. 2024 – 30. 6. 2028
  • Regulation of hypoxic signalling in renal carcinoma with focus on the role of carbonic anhydrase IX in the tumor microenvironment
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
Finished
  • Effects of natural polyphenol and nonsteroidal anti-inflammatory drug combination therapy on the tumor microenvironment
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • Regulation of pyruvate dehydrogenase kinase 1 activity in the control of glycolytic metabolism in hypoxic tumors
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2022
  • Molecular pathways influenced by CA IX in hypoxic cancer cell lines
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2018
  • Impact of LCMV infection on the activity of HIF-regulated signal transduction pathways
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2018
  • Identification of the cellular proteins affected by persistent infection with lymphocytic choriomeningitis virus
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2014
  • Prevalence and medical significance of lymphocytic choriomeningitis virus in Slovak population
    Program: VEGA
    Duration: 1. 1. 2008 – 31. 12. 2010
Employees